![US economy adds fewer jobs than expected in August, increasing odds of 50bp cut](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEH970O1_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.560 | 3.370 | 0.810 |
Stocks | 97.400 | 97.400 | 0.000 |
Bonds | 0.030 | 0.030 | 0.000 |
Other | 0.010 | 0.010 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.253 | 22.218 |
Price to Book | 2.926 | 4.124 |
Price to Sales | 1.799 | 2.386 |
Price to Cash Flow | 15.708 | 17.331 |
Dividend Yield | 1.767 | 1.318 |
5 Years Earnings Growth | 9.662 | 11.877 |
Number of long holdings: 55
Number of short holdings: 8
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Pfizer | US7170811035 | 5.43 | 28.52 | +0.02% | |
AstraZeneca | GB0009895292 | 5.15 | 12,650.0 | +0.88% | |
Novartis | CH0012005267 | 4.45 | 98.60 | -0.31% | |
Siemens Healthineers | DE000SHL1006 | 4.18 | 50.54 | -0.43% | |
UCB | BE0003739530 | 3.97 | 160.40 | +0.50% | |
Eli Lilly | US5324571083 | 3.94 | 903.49 | -1.01% | |
Novo Nordisk B | DK0062498333 | 3.91 | 881.5 | -0.42% | |
UnitedHealth | US91324P1021 | 3.57 | 596.21 | +0.12% | |
Baxter | US0718131099 | 3.48 | 38.92 | +0.26% | |
CVS Health Corp | US1266501006 | 3.46 | 57.69 | -0.66% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
EdR Fund Big Data I USD | 1.97B | 4.37 | 5.17 | - | ||
Melchior Selected Trust European Ou | 467.36M | 9.24 | -1.73 | 6.37 | ||
EdR Fund US Value N USD | 311.23M | 2.75 | 8.19 | - | ||
EdR Fund US Value I USD | 311.23M | 2.62 | 7.84 | 5.90 | ||
EdR Fund US Value R USD | 311.23M | 1.91 | 6.35 | 4.44 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review